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Infections resulting from microbial adhesion to biomaterial sur-
faces have been observed on nearly all medical devices with severe eco-
nomic and medical consequences [1]. Biofilm infections, mainly due 
to their antimicrobial resistance, pose a number of clinical challenges, 
including disease, chronic inflammation, and rapidly acquired antibiot-
ic resistance. Independently of the superiority of the implant, virtually 
all medical devices are prone to microbial colonization and infection. 
Examples of such devices include prosthetic heart valves, orthopaedic 
implants, intravascular catheters, artificial hearts, left ventricular assist 
devices, cardiac pacemakers, vascular prostheses, cerebrospinal fluid 
shunts, urinary catheters, voice prostheses, ocular prostheses and con-
tact lenses, and intrauterine contraceptive devices. 
A large amount of research to eliminate or reduce infections by 
developing anti-infective and anti-adhesive devices has been encour-
aged as a result of the significant resistance of biofilms to conventional 
antibiotic therapies. These improved devices may be produced by either 
mechanical design alternatives; physicochemical modification of the 
biomaterial surface (e.g. biosurfactants, plasma, atom transfer radical 
polymerization, brushes); anti-infective agents bound to the surface of 
the material (e.g. biosurfactants, silver, quaternary ammonium com-
pounds, synthetic antibiotics); or release of toxic agents into the adja-
cent surroundings (e.g. chlorhexidine, antibiotics) [2,3]. The success of 
the mechanical design alternatives has been residual and with limited 
applicability [2]. Furthermore, the effectiveness of coatings designed 
to reduce adhesion by modification of the surface properties has also 
been reduced and greatly dependent on the bacterial species. Surfaces 
modified with poly(ethylene glycol) [4], poly(ethylene oxide) brushes 
[5], and hydrophilic polyurethanes [6], among many others, have been 
reported. Additionally, surface-bounded anti-infective agents are only 
toxic to the initial wave of incoming bacteria and provide little residual 
effects once layers of dead cells accumulate, which are also inflamma-
tory [2]. 
On the other hand, a number of studies demonstrated some suc-
cess in retarding microbial adhesion, and consequently inhibiting or 
delaying biofilm formation. The development of anti-adhesive silicone 
rubber surfaces for voice prostheses constitutes a good example. Since 
voice prostheses are continuously exposed to saliva, food, and drinks, 
together with the commensal microflora, they frequently fail and need 
to be replaced. Therefore, improvement of the antifouling properties of 
the silicone rubber material is highly desirable. Different approaches 
have been undertaken to modify the silicone rubber surface as an obvi-
ous strategy to inhibit biofilm formation and accordingly to prolong the 
lifetime of voice prostheses as reviewed by Rodrigues and collaborators 
[7]. An alternative approach is the design of coatings that actively re-
lease antibacterial agents with high initial fluxes during the first hours 
post-implementation. Nevertheless, it is desirable that release continues 
beyond this short term since fibrous capsule formation and tissue inte-
gration occur over longer periods of time [8]. A recent review on the 
development of antibiotic-releasing biomaterials has been compiled by 
Zilberman and Elsner [9].
Nonetheless, regardless of the method used to release an antibi-
otic from a biomaterial; this action is limited and will end as soon as 
the agent is depleted. Moreover, it is well known that the delivery of 
sub-lethal doses of antibiotics can lead to accelerated biofilm formation 
and induced virulence factor expression [2]. Given that the success the 
above mentioned strategies has been modest, mainly as a result of the 
various environments into which devices are placed and the diversity 
of ways in which organisms can colonize surfaces, the development of 
novel approaches to avoid microbial adhesion onto biomaterials, alter-
native to the traditional surface-modifying preventive ones, is an in-
creasing challenge.
Biosurfactants represent an interesting approach because it may 
be possible to modify the surface properties to make it simultaneously 
anti-adhesive and give it antimicrobial activity. These microbial com-
pounds are amphiphilic molecules with both hydrophilic and hydro-
phobic moieties and with a distinct tendency to accumulate at inter-
faces, thus affecting the adhesion and/or detachment of bacteria. Most 
interfaces have an overall negative or, hardly ever, positive charge. Got-
tenbos and co-workers [10] showed that positively charged biomaterial 
surfaces exert an antimicrobial effect on adhering Gram-negative, but 
not on Gram-positive bacteria. 
Microbial surfactants constitute a diverse group of surface-active 
molecules and are known to occur in a variety of chemical structures, 
such as glycolipids, lipopeptides, fatty acids, neutral lipids, phospho-
lipids, and polymeric structures [11]. The use and potential commer-
cial application in the medical field of these compounds has increased 
during the past decade [11-13]. Due to their antibacterial, antifungal 
and antiviral activities, biosurfactants are useful for combating many 
diseases and as therapeutic agents. Furthermore, their role as anti-ad-
hesive agents against several pathogens suggests their utility as suitable 
anti-adhesive coating agents for biomaterials, leading to new and effec-
tive means of combating colonization by pathogenic microorganisms 
without the use of synthetic drugs and chemicals [11]. 
Many researchers evaluated the potential of different biosurfactants 
as anti-adhesive coatings. For instance, Mireles and collaborators [14] 
pre-coated vinyl urethral catheters by running the surfactin solution 
through them before inoculation with media. As a result, it was found a 
decrease in the amount of biofilm formed by Salmonella typhimurium, 
Salmonella enterica, Escherichia coli and Proteus mirabilis. Also, probi-
otic lactobacilli were tested for the prevention of urogenital infections 
[15,16]. Other examples of the anti-adhesive effect of biosurfactants 
from lactobacilli against uropathogens include the work by Velraeds 
et al. [17] and by Heinemann et al. [18]. Additionally, biosurfactants 
from lactic acid bacteria, namely Streptococcus thermophilus A and 
Lactococcus lactis 53, have been used as a strategy to avoid microbial 
colonization of silicone rubber voice prostheses [19,20]. Although a less 
pronounced anti-adhesive effect was found for yeast strains, over 90% 
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reductions in the initial deposition rates were achieved for most of the 
bacterial strains studied, being these strains responsible for prostheses 
failure. Furthermore, the biosurfactants produced by these lactic acid 
bacteria [21] and by Lactobacillus paracasei ssp. paracasei A20 [22] were 
found to possess antimicrobial and anti-adhesive activity against sev-
eral Gram-positive and Gram-negative bacteria and filamentous fungi. 
The biosurfactant produced by L. paracasei A20 showed anti-adhesive 
activity against Streptococcus sanguis (72.9%), S. aureus (76.8%), S. epi-
dermidis (72.9%) and Streptococcus agalactie (66.6%). These interesting 
findings constitute a promise regarding the potential use of biosurfac-
tants against the adhesion of microorganisms responsible for diseases 
and infections in the urinary, vaginal and gastrointestinal tracts, and 
in the skin.
As discussed above, biosurfactants can play an important role in the 
development of anti-adhesive coatings for silicone rubber or other bio-
materials as they effectively inhibit bacterial adhesion and retard bio-
film formation. Therefore, surface and bulk modification techniques, 
laser-induced surface grafting and the sequential method for interpen-
etrating polymer networks should be explored as ways to link the bio-
surfactants more strongly with the biomaterial surfaces, thus avoiding 
their washout from the surfaces and prolonging their effect. In addi-
tion, being a suitable alternative to antimicrobial agents, biosurfactants 
can be used as safe and effective therapeutic agents. This is currently of 
major interest due to the concerns related with the increasing number 
of drug-resistant microorganisms and the need for alternative thera-
pies [1]. Nevertheless, although biosurfactants constitute an interesting 
alternative to their chemical counterparts, mainly due to their biode-
gradability and low toxicity, it is important to stress that the insufficient 
data on their toxicity for humans, as well as their production costs, have 
been restraining their use in most applications.
The high cost of large-scale production is clearly a constraint for the 
commercialization of biosurfactants. Many biotechnological strategies 
have been pursued to reduce the production costs including the use of 
agro-industrial wastes or others as substrates, optimization of medium 
and culture conditions and efficient recovery processes [23]. However, 
the improvements obtained from these strategies are marginal and to 
successfully compete with synthetic surfactants, novel microorganisms 
must be designed. The use of hyper-producer strains allows increasing 
the production yields and consequently reducing costs. These strains 
can be screened from the natural environment, or engineered using 
synthetic biology approaches. Hence, data on the genes involved on the 
production of biosurfactants is critical for designing organisms with 
improved features. Once the genes have been indentified and isolated, 
they can be expressed in other microorganisms (e.g. to prevent patho-
genicity), or they can be modified or placed under regulation of strong 
promoters to increase their expression and so enhance production. This 
knowledge will also allow the production of novel biosurfactants with 
specific new properties (designed by metabolic engineering and syn-
thetic biology approaches) for different industrial applications. Further 
advances in genetic engineering of the known biosurfactant molecules 
could yield potent biosurfactants with altered antimicrobial profiles 
and decreased toxicity against mammalian cells.
In conclusion, it is fair to say that there is still no absolute solution 
for dealing with microbial adhesion onto medical devices, although 
biosurfactants seem to be potentially useful as a new generation of anti-
adhesive and antimicrobial coatings for such devices. Endeavors and 
challenges related with the genetics and structure-function relation-
ships of biosurfactants, as well as the methods of binding them to sur-
faces, will continue to drive research in this field in the coming years.
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